Today, we announce changes to the executive team. Amy Emerson will step down as CEO; Lykos COO, Michael Mullette, will serve as the interim CEO and Dr. David Hough will assume the role of CMO. We thank Amy for her leadership over the past decade and look forward to the future of working with the FDA to bring this potential new option to people living with PTSD. https://lnkd.in/eBYSZt2z
Thank you for your leadership, Amy! It’s inspirational and has changed lives.
Congratulations Dave Hough!
Amy Emerson Thank you for all you’ve done to push this therapy forward. I hope Lykos Therapeutics continues to put females in leadership, board, and c-suite positions.
Thank you for your leadership Amy Emerson and best of continued success to you Michael Mullette!
Amy Emerson, it's been a privilege to watch you navigate the waters in this emerging sector. Thank you for all your hard work. My husband is alive today because of a chance meeting with Rick many years ago. Hence, my passion for working in psychedelic research. Wishing you much success in your future endeavors, and I hope to collaborate in the near future. Thank you, Amy!
She did a great job! Michael sounds like a great choice to continue to lead the charge
Amy Emerson, words cannot convey the impact of what you have accomplished during your time at MAPS, MAPS PBC, and Lykos. You've transformed the field of mental health, and with it countless lives. It's an honor to have worked alongside you for a decade, and I'm so excited for what's next for you. Thank you.
It’s been a privilege to be a part of your journey over many years, Amy Emerson. Few leaders in this industry have the courage to openly demonstrate the dedication, compassion, and personal regard for employees that have marked your career with MAPS, MAPS PBC, and Lykos. You have worked tirelessly to give rise to the destigmatization of Psychedelic Medicine, and you have changed lives. Can’t wait to see what you do next!
Congratulations Dave! 👏
Amy Emerson thank you for the decade + of support, leadership and dedication to MDMA assisted therapy research and training, Zendo harm reduction services and so much more. Your major, foundational role in spearheading the entire psychedelic medicine industry is undeniable.